Acrivon Therapeutics, Inc. (ACRV) Capital expenditures 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.7MFY2025 · since FY2021: $238,000 → $1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.7M | -39.7% |
| FY2024 | $2.8M | +114.9% |
| FY2023 | $1.3M | -40.5% |
| FY2022 | $2.2M | +810.1% |
| FY2021 | $238,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice